87 related articles for article (PubMed ID: 20817343)
1. Retroperitoneal lymph node dissection with no adjuvant chemotherapy in clinical stage I nonseminomatous germ cell tumours: long-term outcome and analysis of risk factors of recurrence.
Nicolai N; Miceli R; Necchi A; Biasoni D; Catanzaro M; Milani A; Piva L; Pizzocaro G; Stagni S; Torelli T; Salvioni R
Eur Urol; 2010 Dec; 58(6):912-8. PubMed ID: 20817343
[TBL] [Abstract][Full Text] [Related]
2. Management of stage I testicular cancer.
Padayachee J; Clark R; Warde P; Hamilton RJ
Curr Opin Urol; 2022 Jan; 32(1):17-23. PubMed ID: 34772865
[TBL] [Abstract][Full Text] [Related]
3. Critical elements of pediatric testicular germ cell tumors surgery.
Saltzman AF; Hensley P; Ross J; Woo L; Billmire D; Rescorla F; Puri D; Patel S; Pierorazio P; Bagrodia A; Cary C; Cost NG
Semin Pediatr Surg; 2023 Oct; 32(5):151343. PubMed ID: 38006835
[TBL] [Abstract][Full Text] [Related]
4. Evaluation and Management of Testicular Cancer After Late Relapse.
Langner JL; Millard F; Vavinskaya V; Zhang H; Yodkhunnatham N; Bagrodia A
Oncology (Williston Park); 2024 Apr; 38(4):142-146. PubMed ID: 38661513
[TBL] [Abstract][Full Text] [Related]
5. One course of adjuvant BEP in clinical stage I nonseminoma mature and expanded results from the SWENOTECA group.
Tandstad T; Ståhl O; Håkansson U; Dahl O; Haugnes HS; Klepp OH; Langberg CW; Laurell A; Oldenburg J; Solberg A; Söderström K; Cavallin-Ståhl E; Stierner U; Wahlquist R; Wall N; Cohn-Cedermark G;
Ann Oncol; 2014 Nov; 25(11):2167-2172. PubMed ID: 25114021
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Relapse of Clinical Stage I Nonseminomatous Germ Cell Tumors on Surveillance.
Hamilton RJ; Nayan M; Anson-Cartwright L; Atenafu EG; Bedard PL; Hansen A; Chung P; Warde P; Sweet J; O'Malley M; Sturgeon J; Jewett MAS
J Clin Oncol; 2019 Aug; 37(22):1919-1926. PubMed ID: 30802156
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Oncologic Outcomes after Primary Retroperitoneal Lymph Node Dissection: Minimizing the Need for Adjuvant Chemotherapy.
Douglawi A; Calaway A; Tachibana I; Panizzutti Barboza M; Speir R; Masterson T; Adra N; Foster R; Einhorn L; Cary C
J Urol; 2020 Jul; 204(1):96-103. PubMed ID: 32003612
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers of disease recurrence in stage I testicular germ cell tumours.
Lesko P; Chovanec M; Mego M
Nat Rev Urol; 2022 Nov; 19(11):637-658. PubMed ID: 36028719
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in patients with clinical stage I nonseminoma-beyond lymphovascular invasion: a systematic review.
Zengerling F; Beyersdorff D; Busch J; Heinzelbecker J; Pfister D; Ruf C; Winter C; Albers P; Kliesch S; Schmidt S
World J Urol; 2022 Dec; 40(12):2879-2887. PubMed ID: 35906286
[TBL] [Abstract][Full Text] [Related]
10. Minimally invasive retroperitoneal lymph node dissection for men with testis cancer: a retrospective cohort study of safety and feasibility.
Fankhauser CD; Afferi L; Stroup SP; Rocco NR; Olson K; Bagrodia A; Baky F; Cazzaniga W; Mayer E; Nicol D; Islamoglu E; de Vergie S; Saoud R; Eggener SE; Nazzani S; Nicolai N; Hugar L; Sexton WJ; Matei DV; De Cobelli O; Cheaib J; Pierorazio PM; Porter J; Hermanns T; Hamilton RJ; Hiester A; Albers P; Clarke N; Mattei A
World J Urol; 2022 Jun; 40(6):1505-1512. PubMed ID: 35279732
[TBL] [Abstract][Full Text] [Related]
11. Nerve-sparing Robot-assisted Retroperitoneal Lymph Node Dissection: The Monoblock Technique.
Afferi L; Baumeister P; Fankhauser C; Mordasini L; Moschini M; Aschwanden F; Mattei A
Eur Urol Open Sci; 2021 Oct; 32():1-7. PubMed ID: 34667953
[TBL] [Abstract][Full Text] [Related]
12. The 111 Study: A Single-arm, Phase 3 Trial Evaluating One Cycle of Bleomycin, Etoposide, and Cisplatin as Adjuvant Chemotherapy in High-risk, Stage 1 Nonseminomatous or Combined Germ Cell Tumours of the Testis.
Cullen M; Huddart R; Joffe J; Gardiner D; Maynard L; Hutton P; Mazhar D; Shamash J; Wheater M; White J; Goubar A; Porta N; Witts S; Lewis R; Hall E;
Eur Urol; 2020 Mar; 77(3):344-351. PubMed ID: 31901440
[TBL] [Abstract][Full Text] [Related]
13. Developing a Highly Specific Biomarker for Germ Cell Malignancies: Plasma miR371 Expression Across the Germ Cell Malignancy Spectrum.
Nappi L; Thi M; Lum A; Huntsman D; Eigl BJ; Martin C; O'Neil B; Maughan BL; Chi K; So A; Black PC; Gleave M; Wyatt AW; Lavoie JM; Khalaf D; Bell R; Daneshmand S; Hamilton RJ; Leao RRN; Nichols C; Kollmannsberger C
J Clin Oncol; 2019 Nov; 37(33):3090-3098. PubMed ID: 31553692
[TBL] [Abstract][Full Text] [Related]
14. [When is surgical resection of metastases in testicular germ cell tumors indicated and is there a scientific basis?].
Heidenreich A; Paffenholz P; Haidl F; Pfister D
Urologe A; 2017 May; 56(5):627-636. PubMed ID: 28432399
[TBL] [Abstract][Full Text] [Related]
15. Management of stage I testicular germ cell tumours.
Chovanec M; Hanna N; Cary KC; Einhorn L; Albany C
Nat Rev Urol; 2016 Nov; 13(11):663-673. PubMed ID: 27618772
[TBL] [Abstract][Full Text] [Related]
16. Anatomical retroperitoneoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors: initial operative experience.
Yao K; Li ZS; Zhou FJ; Qin ZK; Liu ZW; Li YH; Han H
Asian J Androl; 2014; 16(1):136-9. PubMed ID: 24369147
[TBL] [Abstract][Full Text] [Related]
17. Controversies in the management of stage 1 non-seminomatous germ cell tumors.
Coleman S; Stephenson A
Curr Urol Rep; 2013 Oct; 14(5):506-10. PubMed ID: 23901036
[TBL] [Abstract][Full Text] [Related]
18. Late relapse of testis cancer.
Ehrlich Y; Rosenbaum E; Baniel J
Curr Urol Rep; 2013 Oct; 14(5):518-24. PubMed ID: 23839244
[TBL] [Abstract][Full Text] [Related]
19. Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer.
Beyer J; Albers P; Altena R; Aparicio J; Bokemeyer C; Busch J; Cathomas R; Cavallin-Stahl E; Clarke NW; Claßen J; Cohn-Cedermark G; Dahl AA; Daugaard G; De Giorgi U; De Santis M; De Wit M; De Wit R; Dieckmann KP; Fenner M; Fizazi K; Flechon A; Fossa SD; Germá Lluch JR; Gietema JA; Gillessen S; Giwercman A; Hartmann JT; Heidenreich A; Hentrich M; Honecker F; Horwich A; Huddart RA; Kliesch S; Kollmannsberger C; Krege S; Laguna MP; Looijenga LH; Lorch A; Lotz JP; Mayer F; Necchi A; Nicolai N; Nuver J; Oechsle K; Oldenburg J; Oosterhuis JW; Powles T; Rajpert-De Meyts E; Rick O; Rosti G; Salvioni R; Schrader M; Schweyer S; Sedlmayer F; Sohaib A; Souchon R; Tandstad T; Winter C; Wittekind C
Ann Oncol; 2013 Apr; 24(4):878-88. PubMed ID: 23152360
[TBL] [Abstract][Full Text] [Related]
20. Retroperitoneal lymphadenectomy and resection for testicular cancer: an update on best practice.
Heidenreich A; Pfister D
Ther Adv Urol; 2012 Aug; 4(4):187-205. PubMed ID: 22852029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
